|
Index of reports
> Death (3)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Chorionic Gonadotropin death. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Chorionic Gonadotropin side effects in 53 year old female
Reported by a consumer/non-health professional from United States on 2012-02-21
Patient: 53 year old female, weighing 80.7 kg (177.6 pounds)
Reactions: Pulmonary Embolism
Adverse event resulted in: death
Drug(s) suspected as cause:
Chorionic Gonadotropin
Possible Chorionic Gonadotropin side effects in 61 year old female
Reported by a consumer/non-health professional from United States on 2012-01-04
Patient: 61 year old female
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Chorionic Gonadotropin
Possible Chorionic Gonadotropin side effects in female
Reported by a health professional (non-physician/pharmacist) from Poland on 2011-10-31
Patient: female
Reactions: Neonatal Respiratory Failure, Tumour Necrosis, Hepatoblastoma, Foetal Exposure During Pregnancy, Death Neonatal, Circulatory Failure Neonatal, Caesarean Section, Congenital Hydrocephalus, Abdominal Distension, Feeding Disorder Neonatal, Craniopharyngioma, Cephalo-Pelvic Disproportion
Adverse event resulted in: death
Drug(s) suspected as cause:
Lynestrenol (Linestrenol)
Indication: in Vitro Fertilisation
Nadroparin (Nadroparine)
Indication: Product Used FOR Unknown Indication
Chorionic Gonadotropin
Indication: in Vitro Fertilisation
Estradiol
Indication: in Vitro Fertilisation
Aspirin
Indication: Product Used FOR Unknown Indication
Triptorelin (Triptorelin)
Indication: in Vitro Fertilisation
Follitropin Alfa (Follitropin Recombinant)
Indication: in Vitro Fertilisation
Menotropins
Indication: in Vitro Fertilisation
|
